Leustatin

Active Ingredient(s): Cladribine
FDA Approved: * February 26, 1993
Pharm Company: * ORTHO BIOTECH
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Leustatin Overview

Cladribine, sold under the brand name Leustatin and Mavenclad among others, is a medication used to treat hairy cell leukemia (HCL, leukemic reticuloendotheliosis), B-cell chronic lymphocytic leukemia and relapsing-remitting multiple sclerosis.[4][5] Its chemical name is 2-chloro-2'-deoxyadenosine (2CdA). As a purine analog, it is a synthetic chemotherapy agent that targets lymphocytes and selectively suppresses the immune system. Chemically, it mimics the nu...

Read more Leustatin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Cladribine

Recent Leustatin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Cladribine
  • Injection: 1mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Leustatin: (1 result)

Sorted by National Drug Code
  • 59676-201 Leustatin 1 mg/ml Intravenous Injection, Solution by Janssen Products, L.p.

Other drugs which contain Cladribine or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 21 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA